Anti-PCSK9 (Ralpancizumab)-MC-MMAF ADC

CAT:

708-ADC-W-2314

Size:

1 mg

Price:

Ask

For price, please contact [email protected]

Description: This ADC product is comprised of an anti-PCSK9 monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Format: Solution
Shipping Conditions: Ice Packs
Storage Conditions: -20°C

Cat	Name
ADC-W-2314	Anti-PCSK9 (Ralpancizumab)-MC-MMAF ADC
ADC-W-1684	Anti-PCSK9 (Alirocumab)-MC-MMAF ADC
ADC-W-2230	Anti-PCSK9 (Bococizumab)-MC-MMAF ADC
ADC-W-2316	Anti-PCSK9 (Ralpancizumab)-MC-Vc-PAB-SN38 ADC
ADC-W-1690	Anti-PCSK9 (Lodelcizumab)-MC-MMAF ADC
ADC-W-2380	Anti-PCSK9 (Evolocumab)-MC-MMAF ADC
ADC-W-2315	Anti-PCSK9 (Ralpancizumab)-MC-Vc-PAB-MMAE ADC
ADC-W-2317	Anti-PCSK9 (Ralpancizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC
ADC-W-2313	Anti-PCSK9 (Ralpancizumab)-SPDB-DM4 ADC
ADC-W-2312	Anti-PCSK9 (Ralpancizumab)-SMCC-DM1 ADC

Cat	Name
F1457-.1	Anti-PCSK9 Antibody (Ralpancizumab)
F1457-1	Anti-PCSK9 Antibody (Ralpancizumab)
E24CHB044	Anti-PCSK9 Reference Antibody (ralpancizumab)
YR1326-02	Anti-Human PCSK9 Recombinant Antibody (Ralpancizumab)
YR1326-01	Anti-Human PCSK9 Recombinant Antibody (Ralpancizumab)
MBS3843636-02	MC-Alkyl-Hydrazine Modified MMAF
T18326-50mg	MC-Val-Cit-PAB-MMAF
T18326-10mg	MC-Val-Cit-PAB-MMAF
HY-112786-02	MC-Val-Cit-PAB-MMAF
MBS3843636-03	MC-Alkyl-Hydrazine Modified MMAF